Page last updated: 2024-09-05

somatotropin (6-13) and gliclazide

somatotropin (6-13) has been researched along with gliclazide in 1 studies

*Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion. [MeSH]

*Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion. [MeSH]

Compound Research Comparison

Studies
(somatotropin (6-13))
Trials
(somatotropin (6-13))
Recent Studies (post-2010)
(somatotropin (6-13))
Studies
(gliclazide)
Trials
(gliclazide)
Recent Studies (post-2010) (gliclazide)
1000997214308

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ng, FM1

Other Studies

1 other study(ies) available for somatotropin (6-13) and gliclazide

ArticleYear
A comparison of cellular actions between gliclazide and a hypoglycaemic peptide fragment of human growth hormone (hGH 6-13).
    Diabetes research and clinical practice, 1988, May-19, Volume: 5, Issue:1

    Topics: Adipose Tissue; Animals; Blood Glucose; Cells, Cultured; Gliclazide; Glucose Tolerance Test; Growth Hormone; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Male; Peptide Fragments; Rats; Rats, Inbred Strains; Receptor, Insulin; Reference Values; Sulfonylurea Compounds

1988